Health Care & Life Sciences » Pharmaceuticals | Eli Lilly & Co.

Eli Lilly & Co. | Mutual Funds

Mutual Funds that own Eli Lilly & Co.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard PRIMECAP Fund
28,848,694
2.69%
437,592
4.37%
06/30/2018
Vanguard Total Stock Market Index Fund
24,675,677
2.29%
97,624
0.35%
07/31/2018
Vanguard Health Care Fund
24,222,715
2.25%
-766,700
5.09%
06/30/2018
Vanguard 500 Index Fund
17,297,627
1.61%
19,209
0.41%
07/31/2018
Dodge & Cox Stock Fund
16,568,419
1.54%
3,163,758
2.34%
06/30/2018
SPDR S&P 500 ETF
10,561,573
0.98%
121,954
0.41%
09/06/2018
Vanguard Institutional Index Fund
9,240,270
0.86%
9,859
0.41%
07/31/2018
Government Pension Fund - Global (The)
8,290,970
0.77%
-56,199
0.1%
12/31/2017
Vanguard Wellington Fund
7,668,951
0.71%
56,855
0.8%
06/30/2018
Franklin Income Fund
7,380,703
0.69%
3,380,703
0.94%
03/31/2018

About Eli Lilly &

View Profile
Address
Lilly Corporate Center
Indianapolis Indiana 46285
United States
Employees -
Website http://www.lilly.com
Updated 07/08/2019
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through two segments: Human Pharmaceutical Products and Animal Health. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.